Co-administration of iRGD with peptide HPRP-A1 to improve anticancer activity and membrane penetrability.
about
Co-administration of iRGD with peptide HPRP-A1 to improve anticancer activity and membrane penetrability.
description
2018 nî lūn-bûn
@nan
2018年の論文
@ja
2018年学术文章
@wuu
2018年学术文章
@zh-cn
2018年学术文章
@zh-hans
2018年学术文章
@zh-my
2018年学术文章
@zh-sg
2018年學術文章
@yue
2018年學術文章
@zh
2018年學術文章
@zh-hant
name
Co-administration of iRGD with ...... ty and membrane penetrability.
@en
Co-administration of iRGD with ...... ty and membrane penetrability.
@nl
type
label
Co-administration of iRGD with ...... ty and membrane penetrability.
@en
Co-administration of iRGD with ...... ty and membrane penetrability.
@nl
prefLabel
Co-administration of iRGD with ...... ty and membrane penetrability.
@en
Co-administration of iRGD with ...... ty and membrane penetrability.
@nl
P2860
P1433
P1476
Co-administration of iRGD with ...... ty and membrane penetrability.
@en
P2093
Xiaolong Chen
P2860
P2888
P356
10.1038/S41598-018-20715-4
P407
P577
2018-02-02T00:00:00Z
P6179
1100699267